GATT Technologies, a Dutch provider of hemostatic solutions, has secured 10.5 million euros in Series B financing. NGI LLC led the round with participation from Johnson & Johnson Innovation – JJDC, Inc. and Oost NL.
Source: Press Release
Gatt Technologies snags Series B
GATT Technologies, a Dutch provider of hemostatic solutions, has secured 10.5 million euros in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: